Webcol Alcohol Prep Pads Recalled
March 09, 2026
On March 3, 2026, Cardinal Health issued a voluntary recall of select lots of Webcol™ Large Alcohol Prep Pads
Important Notices
Udenyca Recalled
March 09, 2026
On Feb. 26, 2026, the FDA issued a class I recall for multiple lots of Accord BioPharma’s Udenyca® (pegfilgrastim cbqv) injection, 6mg/0.6mL single dose prefilled syringes.
Urgent Correction Issued for TRUE METRIX Instructions
March 04, 2026
Summary:
On Feb. 6, 2026, Trividia Health initiated an Urgent Medical Device Correction for TRUE METRIX® Blood Glucose Monitoring Systems
True Metrix Blood Glucose Monitoring Systems - Trividia Health Issues Correction
March 03, 2026
Trividia Health, Inc. has issued an Urgent Medical Device Correction to notify affected customers that all TRUE METRIX, TRUE METRIX AIR, and TRUE METRIX GO Self-Monitoring and TRUE METRIX PRO Professional Monitoring Blood Glucose Systems have updated use instructions.
One Lot of Adbry Recalled
February 25, 2026
On Feb. 12, 2026, LEO Pharma initiated a voluntary US recall of Adbry® (tralokinumab ldrm) 300 mg/2mL single dose autoinjector.
Orders may be delayed due to Winter Weather
February 23, 2026
Orders may arrive late due to Winter Weather. We are working with our carriers, so you receive your medication as soon as possible. Please check your tracking information for the latest updates.
Express Scripts sends our best wishes for your safety during this time. Thank you!
FreeStyle Libre 3 Sensors Recalled
December 16, 2025
On Nov. 24, 2025, Abbott Diabetes Care initiated a voluntary recall of select lots of the FreeStyle Libre 3 continuous glucose monitoring sensor.
Famotidine Recalled
November 17, 2025
On Nov. 6, 2025, Fresenius Kabi initiated a voluntary nationwide recall of three lots of famotidine injection, USP, 20mg per 2mL (10mg per mL).
Gammaked Recalled
November 17, 2025
On Nov. 6, 2025, Grifols Therapeutics initiated a voluntary recall of one lot of Gammaked® (immune globulin injection [human]).
Gamunex-C Recalled
October 10, 2025
Grifols Therapeutics LLC issued a voluntary withdrawal of two lots of Gamunex-C® (immune globulin injection [human], 10%) on Sept. 30, 2025, following a rise in reported hypersensitivity reactions associated with the affected vials.